Key result
Cardiac magnetic resonance provides subclinical diagnosis, quantification of severity, risk stratification, and assessment of response to therapy for hypertrophic cardiomyopathy.
This pictorial review highlights the utility of cardiac magnetic resonance in diagnosing, risk stratifying, and assessing therapy response in hypertrophic cardiomyopathy.
May enhance HCM evaluation but should not yet change practice; leaves open prospective outcome trials.
Hypertrophic cardiomyopathy (HCM) is a genetically inherited disease with a wide spectrum of phenotypic presentations. It is crucial to establish an early diagnosis and identify patients at high risk for sudden death. Cardiac magnetic resonance can provide subclinical diagnosis, quantification of severity of known disease, risk stratification, and assessment of response to therapy for HCM. This pictorial review summarizes the main magnetic resonance appearances of HCM and its differential diagnosis.
No takes yet. Share an insight, caveat, or question.
Cannavale et al. (2010) conducted a review in Hypertrophic cardiomyopathy. Cardiac magnetic resonance was evaluated. Cardiac magnetic resonance provides subclinical diagnosis, quantification of severity, risk stratification, and assessment of response to therapy for hypertrophic cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: